The progress made in our understanding of the pathophysiology and treatment of congestive heart failure (CHF) would not have been possible without a number of animal models of heart failure and hypertrophy, each one having unique advantages as well as disadvantages. The species and interventions used to create CHF depends on the scientific question as well as on factors such as ethical and economical considerations, accessibility and reproducibility or the model. How closely the model should mimic the human syndrome of CHF depends on the scientific question under investigation. If the goal is to study pathophysiological processes like remodeling or the function of subcellular systems such as excitation contraction-coupling processes, contractile protein function or energetics, the model of heart failure should mimic the clinical setting as closely as possible. However, if defined causal connections are under investigation such as structure-function analyses or regulation of gene expression, exact reflection of the clinical setting by the animal model may be less important. In this review, animal models of heart failure are discussed with particular focus on similarities between the animal model and the failing human heart regarding myocardial function as well as molecular and subcellular mechanisms. In addition, new models of heart failure and hypertrophy, and finally some recent animal models of myocarditis are reviewed.
Introduction
selected patients under state-of-the-art medical therapy, 1 year mortality ranged between 35% in patients with severe During the last decade, considerable advances in our congestive heart failure (NYHA IV) in the Consensus trial understanding and management of heart failure have been [3] to 9 and 12% in patients with moderate CHF (NYHA made. However, with increasing life expectancy and II-III) in the second Vasodilator Heart Failure Trial [4] decreasing mortality of acute myocardial infarction and and the Studies of Left Ventricular Dysfunction (SOLVD) other conditions that may cause heart failure, the incitrial [5] . Mechanisms of death include sudden death in dence, prevalence, mortality and economic costs of the about 40%, worsening of heart failure in about 40% and disease are steadily increasing. The overall prevalence of other factors in 20% of the patients. congestive heart failure (CHF) is 1 to 2% in middle-aged and older adults, reaches 2 to 3% in patients older than age 65 years, and is 5 to 10% in patients beyond the age of 75 2. What are the characteristics of human heart years [1] . Survival of patients suffering from heart failure failure? depends on the duration and severity of the disease, on gender, as well as on therapeutic strategies. In the FraminHuman heart failure has many underlying causes, the gham study, the overall 5-year survival rates were 25% in frequencies of which have changed considerably during the men and 38% in women [2] . In recent clinical trials with last decades. At present, the leading cause is coronary heart disease which accounted for 67% of CHF cases in the 1980s according to the Framingham heart study [2] . systemic vascular resistance. There is considerable eviMost of these patients also had a history of arterial dence that endothelial dysfunction contributes to altered hypertension (57%). Valvular heart disease underlies failhemodynamics during rest and particularly to altered ure in about 10% of the patients, and 20% of heart failure hemodynamics during exercise (for review see [15] ). cases are attributable to primary myocardial diseases, of Endothelial dysfunction appears to result from remodeling which dilated cardiomyopathy predominates. Regardless of of resistance arterioles and capillaries, from increased the original cardiac abnormality, however, the advanced synthesis of endothelin, and from decreased synthesis of heart failure syndrome presents a complex picture includnitric oxide [16, 17] . ing disturbed myocardial function, ventricular remodeling, altered hemodynamics, neurohumoral activation, cytokine overexpression, as well as vascular and endothelial 2.3. Myocardial alterations dysfunction.
At the level of the myocardium, characteristic func-2.1. Neurohumoral and cytokine activation tional, biochemical and molecular alterations occurring in end-stage heart failure have been described. Several Independent of the etiology of heart failure, activation of studies have suggested that disturbed excitation-contracthe neurohumoral and the cytokine system seems to play a tion coupling processes may underlie disturbed myocardial critical role in the prognosis in CHF [6] [7] [8] . Activation of function [18] [19] [20] [21] [22] [23] [24] . This may be related to disturbed sarcothe neurohumoral systems occurs stepwise and is organ plasmic reticulum function due to decreased expression specific. It was shown recently, that increased cardiac and activity of the sarcoplasmic reticulum calcium pump adrenergic drive precedes generalized sympathetic activaand increased expression and function of the sarcolemmal tion in patients with mild CHF [9] . This results from sodium-calcium exchanger (for review see [25] ). In increased norepinephrine release and decreased norepiaddition, disturbed energy metabolism may be involved in nephrine reuptake and seems to be associated with early decreased sarcoplasmic-reticulum calcium transport [26] . attenuation of cardiac and arterial baroreceptor control of Although myosin content may be decreased by about sympathetic tone [10, 11] . Similarly, atrial natriuretic pep-20% due to replacement by connective tissue [18] , maxitide is activated early in heart failure, and it was shown mum calcium-activated force was suggested to be similar that atrial natriuretic peptide is elevated in asymptomatic in failing and nonfailing human myocardium [27, 28] . This patients with left ventricular dysfunction [12] . Although may be because force-time integral production of the activation of local renin-angiotensin systems may occur individual crossbridge cycle is increased in the failing early, plasma-renin activity and vasopressin release are heart, associated with a reduced myofibrillar ATPase only increased in patients with symptomatic heart failure activity [18, 29] . Previous studies suggested that unlike the [12] . situation in small mammals, alteration of crossbridge Recent studies have identified the importance of cytofunction may not be related to a myosin isoform shift, kines as mediators of disease progression by mechanisms because it was observed that the ß-myosin heavy-chain including necrotic and / or apoptotic myocyte cell death, isoform predominates in the left ventricle of nonfailing and myocardial fibrosis, and depression of myocardial function failing human hearts [30] . This is in contrast to more (for review see [13] ). The influence of the vasoconstrictor recent studies in which at the level of mRNA ventricular peptide, endothelin has been extensively investigated. Both expression of a-myosin heavy-chain isoform was observed mature endothelin-1 and its precursor, big endothelin-1, are in nonfailing hearts, which was decreased in failing human increased in the peripheral circulation in relation to the hearts [31, 32] . Alternatively to a myosin isoform shift, the hemodynamic and functional severity of heart failure, and alteration in crossbridge function may, however, be related plasma levels of big endothelin-1 are correlated with the to changes in troponin T isoforms or alterations in myosin prognosis of patients with heart failure [14] . Similarly, light chains [33, 34] . Controversy exists regarding alteracirculating levels of tumor necrosis factor-a (TNF), of tion of myofilament calcium sensitivity as measured in TNF receptors and of interleukin-6 are increased and myofibrillar preparations which was suggested to be positively related to the severity of heart failure [8] . TNF is unchanged [35, 36] or increased [37] . Wolff et al. suggested expressed in the failing but not in the nonfailing human that calcium sensitivity is increased in failing myocardium heart whereas TNF receptors (TNFR1 and TNFR2) are from hearts with dilated cardiomyopathy which may be expressed in failing and nonfailing myocardium [7] . due in part to a reduction of protein kinase A-dependent phosphorylation of myofibrillar regulatory proteins [38] .
Hemodynamic abnormalities
Many studies have shown that the b-adrenergic signal transduction pathway is altered in the failing human heart. Hemodynamic abnormalities in patients with advanced
This results from a decrease in myocardial b1-adrenocongestive heart failure include elevated filling pressures, ceptor density which is partly due to decreased expression reduced cardiac output and increased pulmonary and of the b1-adrenoceptor gene demonstrated both at the at Pennsylvania State University on http://cardiovascres.oxfordjournals.org/ Downloaded from mRNA and protein levels [39, 40] . In addition, G mRNA dysfunction and myocardial failure is associated with ia and protein concentrations are increased which may further neurohumoral activation similar to that seen in patients inhibit adenylyl cyclase activity in failing human hearts with CHF [51] [52] [53] [54] . In particular, it was shown that ACE [41] . activity in the left ventricle correlated inversely with left Regarding extracellular matrix in human CHF, it was ventricular function and that ACE activity in the kidney shown that connective tissue content is increased and that was only increased late after the induction of heart failure changes in collagen composition occur [42, 43] .
[55]. Depressed myocardial function is associated with altered calcium transients [56] . The density of L-type calcium channels, as evaluated by antagonist binding was 3. Animal models of heart failure and hypertrophy shown to be decreased in moderate to severe stages of congestive heart failure [57, 58] . Furthermore, it was shown During the period from [1993] [1994] [1995] [1996] [1997] 1943 papers have that after 4, 8 and 16 weeks following coronary artery 21 been published on studies performed in animal models of ligation, SR-Ca -ATPase mRNA and protein levels deheart failure ( Table 1 ) and hypertrophy ( Table 2) . Most crease continuously with increasing severity of congestive 21 studies have been performed in rats with different intervenheart failure. Interestingly, SR-Ca -ATPase activity was tions to induce hypertrophy and heart failure.
found to be more depressed than expected from the reduction in protein levels [59] . Although a high initial mortality and induction of mild 4. Rat models of heart failure failure in most cases may be a disadvantage of this model it seems to be very useful for long-term studies of 4.1. What are the advantages and disadvantages of pharmacological interventions on the neurohumoral activausing a rat model of heart failure?
tion. Of note, it was recently shown that ligation of the left Rat models are relative inexpensive and because of short descending coronary artery in Lewis inbred rats produces a gestation periods, a large sample size can be produced in a uniformly large infarct with low mortality. This model, relatively short period of time. Therefore, rat models have therefore, may be of advantage over the Sprague-Dawley been extensively used to study long-term pharmacological rat model [60] . interventions including long-term survival studies [44, 45] . However, there are several limitations to the use of rat 4.3. Rat aortic banding models regarding differences in myocardial function compared to the human heart: (1) Rat myocardium exhibits a Suprarenal aortic coarctation results in a very short very short action potential which normally lacks a plateau reactive hyperreninemia of less than 4 days. Thereafter, the phase [46] . (2) Calcium removal from the cytosol is circulating renin-angiotensin system is no longer actipredominated by the activity of the sarcoplasmic reticulum vated, but the ventricular ACE activity begins to rise. After 1 21 calcium pump whereas Na / Ca -exchanger activity is a period of several weeks, ventricular ACE activity may less relevant [46, 47] . (3) In normal rat myocardium, adecrease again to normal values which may be related to myosin heavy-chain isoform predominates and a shift normalization of wall stress with increasing hypertrophy towards the b-myosin isoform occurs with hemodynamic [61] . Numerous studies have been performed using aortic load or hormonal changes [48] . (4) Resting heart rate is banding in rats to evaluate different aspects of left venfive times that of humans and the force-frequency relation tricular hypertrophy. Furthermore, after several months, a is inverse [46] . subset of animals goes into failure. In a recent study, chronic experimental aortic constriction imposed by band-4.2. Rat coronary ligation model ing of the ascending aorta in weanlings resulted in compensated left ventricular hypertrophy of the adult rats Myocardial infarction following coronary artery ligation for several weeks. After 20 weeks of aortic banding two in Sprague-Dawley rats is a widely used rat model of distinct groups could be identified: rats without change in heart failure. If the left coronary artery is not completely LV systolic pressure development and those with a signifiligated, heart failure may occur as a consequence of cant reduction in left ventricular systolic pressure [62] . The chronic myocardial ischemia [49] . Complete occlusion of latter group exhibited increased left ventricular volumes, the left coronary artery results in myocardial infarction of reduced ejection fraction and clinical signs of overt heart variable sizes with occurrence of overt heart failure after failure [63] . Left ventricular hypertrophy and failure was 3-6 weeks in a subset of animals with large infarcts. The associated with increased b-myosin heavy chain mRNA impairment of left ventricular function is related to the loss and atrial natriuretic factor mRNA. Interestingly, a de- 21 of myocardium. Failure is associated with left ventricular crease in SR-Ca -ATPase mRNA levels by the polydilatation, reduced systolic function and increased filling merase chain reaction occurred in left ventricular myocarpressures [44, 50] . The progression of left ventricular dium from failing animals after 20 weeks of banding but [194, 195] Transition from compensated right ventricular hypertrophy to failure a Turkey 9 Toxic cardiomyopathy [196] Alteration of calcium handling and myocardial energetics a Bovine 25 Genetic [197] Similar to human heart failure regarding changes in b-adrenergic system a Sheep 17 Pacing tachycardia [198, 199] Similar to dog and swine model of pacing tachycardia
Aortic constriction [200] Transition from compensated hypertrophy to left ventricular dysfunction a Total number of references in this species (failure and animal species) 1993-1997. Transgenic animals see Table 3 not in nonfailing hypertrophied hearts. From this data, it transition from hypertrophy to failure at the level of the 21 was suggested that the decrease in SR-Ca -ATPase myocardium. Nevertheless, one should keep in mind that mRNA levels may be a marker of the transition from considerable differences in the function of subcellular compensatory hypertrophy to failure in these animals [62] .
systems exist between rat and human myocardium [46] . During compensated hypertrophy, while catecholamine levels are normal, there is activation of the local myocar-4.4. Dahl salt-sensitive rats dial renin-angiotensin system, which may be important for the development of myocardial failure [64] . With the Another animal model which may be suited to study the development of heart failure, plasma catecholamine levels transition from compensated hypertrophy to failure is the can increase [65] .
Dahl salt-sensitive rat [66, 67] . This strain of rats develops This model seems to be well suited for studying the systemic hypertension after receiving a high-salt diet. This results in concentric left ventricular hypertrophy at 8 5. Dog models of heart failure weeks, followed by marked left ventricular dilatation and overt clinical heart failure at 15-20 weeks. Failing rats die 5.1. What are the advantages and disadvantages of within a short period of time. Heart failure is associated using dog models of heart failure? with reduced myocardial performance as shown in isolated muscle strip preparations [67] .
Generally, dog and other large animal models of heart failure may allow the study of left ventricular function and volumes more accurately than rodent models. In particular, 4.5. Spontaneous hypertensive rats (SHR) they better allow chronic instrumentation. Furthermore, in dog, like in human myocardium, the b-myosin heavy-chain The spontaneous hypertensive rat (SHR) is a wellisoform predominates and excitation-contraction coupling established model of genetic hypertension in which cardiac processes seem to be similar to the human myocardium pump function is preserved at 1 year of age [68] . At 18-24 [77] . The force-frequency relation, as evaluated by E , max months, cardiac failure develops which includes reduced the slope of the end-systolic pressure-volume relation, was myocardial performance and increased fibrosis. In this shown to be positive in autonomically intact awake dogs as model, although altered calcium cycling was observed, no well as during autonomic blockade [78] . On the other decrease in mRNA of the sarcoplasmic reticulum calcium hand, dog models are costly and require substantial pump was found during the transition from compensated resources with respect to housing and care. hypertrophy to failure [69, 70] . It was suggested that the transition to failure is associated with significant alterations 5.2. Chronic rapid pacing in the expression of genes encoding extracellular matrix [70] . Furthermore, an increased number of apoptotic Chronic rapid pacing at heart rates above 200 beats per myocytes was observed, and it was suggested that apopminute in previously healthy dogs within several weeks tosis might be a mechanism involved in the reduction of produces the syndrome of congestive heart failure [79] [80] [81] . myocyte mass that accompanies the transition from stable
In the majority of studies, chronic pacing tachycardia compensation to heart failure in the model. Interestingly, results in progressive biventricular chamber dilatation over the angiotensin-converting enzyme inhibitor captopril was a 3-4 week period. This is associated with a significant associated with reduction in the exaggerated apoptosis that decrease in ejection fraction and diastolic dysfunction, accompanied CHF [71] .
followed by decreased cardiac output and increased systemic vascular resistance [80, 82, 83] . It is important to note 4.6. SH-HF rats that the changes in LV geometry and function are not accompanied by significant changes in LV mass and Spontaneously hypertensive rats which develop failure hypertrophy [80, 81] . In addition, heart failure has been before 18 months of age have been selectively bred (SHshown to be reversible with respect to clinical, hemo-HF). Development of heart failure occurs earlier in SHdynamic and neurohumoral abnormalities when pacing is HF rats which carry the facp (corpulent) gene, which stopped [84] . The exact pathogenesis in this model is still encodes a defective leptin receptor (SH-HF / Mcc-facp) unclear. [72] . In these animals, renin-plasma activity, atrial natSimilar to human heart failure, there are time-dependent riuretic peptide, and aldosterone levels progressively inchanges in neurohumoral activation with an early sympacrease with age, and renin-plasma activity is independently thetic activation, increase in catecholamine plasma levels correlated to cardiac hypertrophy [73] . Interestingly, hearts and attenuation of parasympathetic tone [85, 86] . In addifrom the SH-HF rat exhibit a more negative forcetion plasma ANP levels are elevated early in the developfrequency relationship than control rats [74] . In a recent ment of left ventricular dysfunction [87] . Systemic activastudy performed in SH-HF, Gomez at al. suggested that tion of the renin-angiotensin system is seen with progrescalcium current density, density and function of ryanodine sive pump failure [86, 88] . Furthermore, endothelial receptors, and sarcoplasmic reticulum calcium uptake are dysfunction with decreased agonist-stimulated and flow normal. However, they showed that the relationship bestimulated nitric-oxide mediated coronary vasodilation has tween calcium current density and the probability of been observed similar to the situation in patients with heart evoking a spark was reduced indicating that calcium influx failure [89] . is less effective at inducing SR calcium release. It was Consistent with the findings in failing human hearts, speculated that these changes may be related to spacial force-frequency relation is blunted or inversed in the remodeling between L-type calcium channels and pacing tachycardia failure dog model [90, 91] . Altered ryanodine receptors [75] . Of note, a recent report showed force-frequency relation in this model was also observed 21 that Ca -dependent NOS activity and expression of at the level of the isolated myocyte [92] . Komamura et al. endothelial NOS is increased in hypertensive SH-HF rats observed that failing animals do not further augment stroke [76] .
volume by an acute increase in preload, suggesting that the Frank-Starling reserve is exhausted under in vivo condeath which may be related to prolongation of the action ditions [93] .
potential [105] . Interestingly, action potential prolongation At the level of the myocardium, contractile force has could be reversed by adenovirus mediated transfer of been shown to be decreased and calcium transients were potassium channels (AdShK) in isolated myocytes from prolonged [94] . Furthermore, Zile et al. showed that failing dog hearts [106] . relaxation is impaired in isolated myocytes from failing In summary, the pacing-tachycardia dog model seems hearts [95] .
very valuable for studying neurohumoral mechanisms and This may be related to altered expression and function peripheral circulatory alterations, both of which closely of calcium-handling proteins. Although, an earlier report resemble that observed in human heart failure. Further- 21 suggested that SR-Ca -ATPase mRNA levels measured more, alterations in myocardial function and molecular in left ventricular endocardial biopsies at baseline and at changes in calcium-handling proteins underlying altered the onset of pacing tachycardia-induced failure do not myocardial function show considerable similarities to the significantly change [96] , more recent data indicates that failing human heart. This may allow the study of the rapid pacing model include an uncertain pathogenesis, and showing a decreased activity of the SR calcium pump in lack of long-term stability because heart failure is reversmongrel dogs with pacing-induced heart failure and in ible when pacing is stopped. Furthermore, unlike clinical Doberman Pinscher dogs with dilated cardiomyopathy forms of CHF, the development of CHF by chronic rapid [98] . Thus altered calcium handling may result from pacing is not associated with hypertrophy or increased reduced SR calcium uptake and accumulation and incollagen content. Loss of collagen support may consideracreased calcium sequestration into the extracellular space.
bly contribute to ventricular remodeling in this model. In addition, a decreased number of ryanodine receptors has
The technique of tachycardia pacing to induced heart been suggested in a study by Cory et al. [98] . Consistently, failure has also been used in pigs and sheep and findings . pacing and remained at this depressed level up to 4-7 weeks of pacing when heart failure was manifest [99] . In 5.3. Coronary artery ligation and microembolization the same study, dihydropyridine binding was not altered in the failing animals [99] .
Coronary artery ligation and microembolization have Whether altered myofilament calcium sensitivity contribeen used to produce myocardial infarction and CHF in butes to altered myocardial function in this model is not dogs. In closed-chest dogs, approximately up to 7 emboliclear [100, 101] .
zation procedures are performed 1-3 weeks apart. Three Considerable changes seem to occur in myocyte shape, months after the final microembolization, there are clinical in cytoskeleton and in the extracellular matrix. In contrast signs of heart failure, there is left ventricular dilatation, to findings in human heart failure, collagen content was decreased ejection fraction, and neurohumoral activation shown to be decreased and its structure was altered which similar to that observed in humans [111] . A decreased may result in decreased collagen support [102] . Changes in number of b-adrenoceptors and L-type calcium channels cytoskeleton and extracellular matrix were suggested to be have been observed 3 months after the final embolization a major factor for ventricular remodeling, and apoptotic procedure [112] . Furthermore, sarcoplasmic reticulum 21 cell death was also suggested to play a key role in the Ca -ATPase activity and protein levels were reduced in development of CHF [103, 102] . left ventricular myocardium from failing animals [113] . Significant alterations have been observed in the bWith this model, the progression from left ventricular adrenoceptor-adenylyl-cyclase system. These include dedysfunction to heart failure and the influence of pharmacocreased b-adrenergic receptor density [102] . Unlike the logical interventions can be studied [114] . situation in human heart failure, mRNA levels of adenylyl-
The model has several disadvantages. Because of extencyclase have been shown to be reduced consistent with sive collateral circulation, there are important differences reduced basal and forskolin-stimulated adenylyl cyclase in the pattern of infarction between the human and the dog. activity [104] .
The model is time consuming, technically demanding and Similar to human CHF, this model was shown to be expensive. The model is associated with high mortality and associated with malignant arrhythmias and sudden cardiac with a high incidence of arrhythmias.
Transmyocardial direct-current shock
the diaphragm. Heart failure occurs about 4 weeks after the initial procedure [123, 124] . Heart failure is associated with A number of transmyocardial direct-current shocks alterations in the b-adrenoceptors system similar to those applied through a catheter into the left ventricular chamber in humans [123] . Furthermore, in this model there is in anesthetized dogs, results in left ventricular hypertrophy inversion of the force-frequency relation and alteration of and dilatation, decreased ejection fraction and decreased post-rest potentiation which closely resembles the situation cardiac output over a 4-months period [115] . This is in the human heart [125] . Interestingly, protein and mRNA 1 21 associated with increased plasma catecholamines but with levels of Na / Ca -exchanger were significantly inno change in plasma renin activity [115] .
creased in failing compared to nonfailing animals whereas 21 sarcoplasmic reticulum Ca -ATPase was not significantly 5.5. Volume overload altered [126] . This may indicate that increased transsar- 1 21 colemmal calcium loss by increased Na / Ca -exchanger In dogs, volume overload has been produced by creation activity my decrease calcium availability to contractile of an arteriovenous fistula or by destruction of the mitral proteins and decrease myocardial function even without valve [116, 117] . Chronic experimental mitral regurgitation direct alteration of sarcoplasmic reticulum function. produced in closed-chest dogs by disruption of mitral Because this model closely mimics alterations of chordae or leaflets using an arterially placed grasping myocardial function observed in the end-stage failing forceps results in left ventricular hypertrophy and dilatahuman myocardium, this model may be well suited to tion within 3 months and development of overt clinical study alterations in excitation-contraction coupling proheart failure occurs in this model [117] . Neurohumoral cesses occurring during the transition from compensated activation including local activation of the RAS was hypertrophy to failure. observed which is associated with depressed myocardial function [118] [119] [120] . The model has been used to study the 6.3. Tachycardia-pacing influence of chronic b-adrenoceptor blockade on myocyte and left ventricular function which both significantly Recently, chronic rapid pacing at rates between 350 and improved with this treatment [120] . 400 beats per minute over a period of several weeks in rabbits was shown to produce myocardial depression as well as clinical, hemodynamic and neurohumoral signs of 6. Rabbit models of heart failure heart failure [127] [128] [129] . Regarding myocardial function, force-frequency relation was severely depressed and in-6.1. What are the advantages and disadvantages of verted at higher stimulation rates [130] . This is similar to using a rabbit model of heart failure?
the alteration of the force-frequency relation observed in failing human hearts. As was observed in the tachycardiaRabbit models are less expensive than dog models. In pacing dog failure model, no left ventricular hypertrophy is addition, nonfailing rabbit myocardium exhibits interesting developed in the rabbit model. Interestingly, Eble et al. similarities to the human heart: (1) The b-myosin heavyrecently showed that although the rate of myosin heavy chain isoform predominates in adult animals, (2) the chain (MHC) synthesis was increased, left ventricular sarcoplasmic reticulum contributes by about 70% and the MHC content was not increased [131] . The authors
Na / Ca -exchanger contributes by about 30% to calcium suggested that accelerated degradation may contribute to elimination, (3) the force-frequency relation is positive the failure of myocardial hypertrophy in this model [131] . [121, 46, 47] .
These findings may also be relevant for pathophysiology of tachycardia-pacing induced CHF in other animal species 6.2. Volume and pressure overload Volume overload, pressure overload and the combina-6.4. Doxorubicin cardiomyopathy tion of both are used to induce heart failure in rabbits. Chronic severe aortic regurgitation in rabbits, created by Doxorubicin exhibits acute and chronic cardiotoxicity aortic valve perforation with a catheter, produces left and has been used to induce failure in various animal ventricular hypertrophy, followed by systolic dysfunction species. Several different mechanisms involved in the and heart failure after a period of months [122] . Occurpathophysiology of doxorubicin-induced heart failure have rence of heart failure is more consistently and rapidly been suggested including free radical generation and lipid observed when aortic regurgitation is combined with aortic peroxidation, reactive sulfhydryl groups, binding to chanconstriction. In the model developed by Ezzaher et al., nel regulatory sites, or inhibition of mRNA and protein aortic insufficiency is produced by destroying the aortic synthesis [132] . valve with a catheter introduced through the carotid artery.
In a recent study, doxorubicin, given intravenously twice After 14 days, aortic constriction is performed just below weekly for 6-9 weeks resulted in myocardial failure, the [132] .
Interestingly, this alteration in gene expression preceded any noticeable myocyte damage [143] . On the other hand, Whitmer et al. observed that sarcoplasmic reticulum 7. Guinea pig models calcium uptake is decreased in 9-month-old animals exhibiting heart failure but not in hypertrophic hearts without 7.1. Aortic banding signs of heart failure [140] . Enhanced activity of the 1 21 Na / Ca -exchanger in failing animals was recently Following 8 weeks of banding of the descending suggested from electrophysiological measurements [144] . thoracic aorta in guinea pigs, overt heart failure develops Furthermore, time-dependent changes in myosin isoform in a subgroup of animals [133] [134] [135] . Alteration of myocarexpression has been observed [145] . dial function in this guinea pig model has some similarities Recently, a genetic linkage map localized the carwith end-stage failing human myocardium. Siri et al.
diomyopathy locus on hamster chromosome 9qa2.1-b1 showed that the force-frequency relation is blunted in [146] . Furthermore, it was shown that the cardiomyopathy isolated myocytes from failing hearts [133] . Furthermore, a results from a mutation in the delta-sarcoglycan gene 21 decrease in SR-Ca -ATPase protein levels and phos- [147] . pholamban protein levels was observed in failing guinea
In summary, the advantages of this model are (1) pig hearts following 8 weeks of banding of the descending absence of surgical manipulations, (2) low costs and (3) thoracic aorta as compared to an age-matched banded the ease with which large numbers of animals can be group without clinical signs of heart failure [134]. Regardstudied. It is important to state that there are differences ing myosin isoforms, guinea pig myocardium, like the among the strains, and in the time course of the pathologic human ventricular myocardium, contains predominantly changes, and therefore, the time point at which measurethe b-myosin heavy chain with small amounts of aments are performed is critically important in this model. myosin. This is shifted completely to b-myosin without Furthermore, subcellular alterations underlying myocardial any a-myosin heavy chain present in hypertrophied and failure seem to be different from those in failing human failing hearts [135] .
hearts. These studies show that this guinea pig model has similarities to human heart failure with respect to calcium cycling, myosin isoforms and myocardial function. This model may be suited to study the transition from cardiac 9. Recent models of CHF in mice hypertrophy to failure with respect to alterations in excitation-contraction coupling systems.
The recent development of techniques to alter specifically the expression of genes greatly improved our understanding of the pathophysiology of heart failure.
Syrian hamster
Moreover, several genetic models of heart failure by addition or deletion of genes in mice have been developed 8.1. Cardiomyopathic hamster and miniaturized physiological techniques to evaluate the resulting cardiac phenotypes have been established Cardiomyopathic strains of the Syrian hamster have [148, 149] . These models allow the identification of genes been widely used as a model for cardiac hypertrophy and that are causative for heart failure and to evaluate molecuheart failure [136] . The model exhibits an autosomal lar mechanisms responsible for the development and recessive mode of inheritance [136, 137] . The cardiac progression of the disease (Table 3) . disease proceeds progressively in several histologic and Gene-targeted disruption of the muscle LIM protein clinical phases during the life of the animal and overt heart (MLP) in mice is a new model of dilated cardiomyopathy failure develops after 7-10 months. Histologically, neand heart failure [150] . MLP is a regulator of myogenic crotic, calcified myocardial lesions are observed initially in differentiation. Mice which are homozygous for the MLP the development of the disease. Microvascular spasms and knockout develop dilated cardiomyopathy associated with disturbed calcium handling have been suggested to be myocardial hypertrophy, interstitial cell proliferation and relevant for the pathophysiology in this model and benefifibrosis. Adult mice show clinical and hemodynamic signs cial effects of verapamil have been observed [138] [139] [140] .
of heart failure similar to those in humans. Because of The density of L-type calcium channels seems to be these similarities, it was suggested that molecular mechaincreased in younger animals before morphological evinisms resulting in MLP dysfunction may be involved in at Pennsylvania State University on http://cardiovascres.oxfordjournals.org/ Downloaded from Table 3 insulin-like growth factor 1 gene, and the nerve growth Transgenic models of heart failure and hypertrophy factor (NGF) [155, 156] .
Intervention Phenotype Reference
Cardiomyopathy was also observed in a tropomodulinoverexpression model and in transgenic mice expressing
Gene overexpression C-myc
Myocardial hyperplasia [221] Epstein-Barr virus nuclear antigen-leader protein or polyEpstein-Barr virus Dilated cardiomyopathy [157] oma virus large T-antigen [157, 158] 10. Recent animal models of hypertrophy myofibrillar disarray Interleukin b and Hypertrophy [167] Numerous animal models have been developed in the interleukin b receptor past and applied to study molecular mechanisms and
Nerve growth factor Cardiomyopathy [155] functional aspects of myocardial hypertrophy ( Animal models of hypertrophy which allow the study of
Gene mutation
the transition from compensated hypertrophy to heart a-cardiac myosin heavy Hypertrophic [162] failure have been discussed in the sections above and chain cardiomyopathy hypertrophy associated with hypertension is addressed in
Lack of b-myosin light Hypertrophic [163] the review by Pinto and Ganten [160] . [182] Hypertrophic cardiomyopathy is a complex cardiac factor b disease in humans which is caused by a genetic malformaInterferon regulatory Myocarditis and failure [181] tion of the heart. The disease can be caused by a mutation factor 1 in at least one of four genes that encode proteins of the cardiac sarcomere: the b-myosin heavy chain, cardiac the development of human dilated cardiomyopathy and troponin T, a-tropomyosin and myosin-binding protein C CHF [150] .
gene. In addition, mutations in the two genes encoding the Development of cardiomyopathy was also observed in myosin light chains that may cause a rare form of the mice with knockout of myogenic factor 5 [151] .
disease, have been reported and other genes that cause the Another mouse model of dilated cardiomyopathy is disease are likely to be found. Clinically the disease is overexpression of the cardiac stimulatory G protein a characterized by asymmetrical left ventricular hypertrophy, subunit (G ). In this model, chronic sympathetic stimulamyofiber disarray, diastolic left ventricular dysfunction, s a tion was suggested to be the cause of cardiomyopathy. and increased incidence of sudden death. The clinical Older mice exhibited left ventricular dilatation and course varies markedly depending on the type of mutation dysfunction and increased mortality [152] . and other unknown factors (for review see [161] ). Transgenic mice overexpressing either b-adrenergic A transgenic mouse model of the disease (a point   403 receptor kinase or G protein-coupled receptor kinase 5, mutation of the Arg -Gln in the a-myosin heavy-chain resulting in uncoupling of the b-adrenergic receptors, also gene) has been developed which exhibits similarities to exhibit reduced contractility but without clinical signs of human familial hypertrophic cardiomyopathy [162] . A overt CHF [153, 154] . similar phenotype was recently observed in transgenic Myocyte hyperplasia and dilated cardiomyopathy have mice lacking the light chain binding domain of the bbeen observed in animals with overexpression of the myosin heavy chain [163] . These models will allow the study of the still unknown pathophysiological mechanisms associated with increased activity and expression of iNOS, of the disease.
and an inhibitor of iNOS effectively attenuated histopathological changes. Accordingly, it was concluded that 10.2. Transgenic models of hypertrophy NO may play an important role in mediating pathophysiological changes in myocarditis of autoimmune Other transgenic mice models of hypertrophy have been origin [177] . developed (Table 3) . Overexpression of the H-ras gene Autoimmune myocarditis has also been induced with targeted to ventricles with the MLC2v promotor causes various intracellular antigens. When CAF1 / J mice were ventricular hypertrophy including myofiber disarray, obimmunized with a monoclonal anti-dog sarcoplasmic re-21 struction of the left ventricular outflow tract, and diastolic ticulum, Ca -ATPase antibody myocarditis developed dysfunction [164, 165] . [178] . Furthermore, myocarditis and decreased cardiac Overexpression of calmodulin, a calcium-binding profunction was observed after immunization of guinea pigs tein, can also induce cardiac hypertrophy in transgenic with the isolated ADP/ATP carrier protein [179] . mice [166] .
Recently, transgenic knockout models of different comHypertrophy was also induced in transgenic mice overponents of the immune system have provided useful expressing interleukin 6 and the interleukin 6 receptor insights in the pathogenesis of viral myocarditis (for associated with activation of gp130, the latter was sugreview see [180] ). An interesting mouse myocarditis model gested to mediate hypertrophic response in this model was established by knocking out the gene encoding the [167] .
interferon regulatory factor-1. This factor plays an imChronic activation of the a -adrenergic receptor pathportant role in the regulation of interferon expression. 1 way also results in hypertrophy in transgenic mice overInactivation of the gene in mice leads to a pronounced expressing the a -adrenergic receptor [168] .
susceptibility to Coxsackie-viral myocarditis [181] . 1 Recently, a mouse transgenic model for mitochondrial Knockout of the gene of transforming growth factor b1 myopathy exhibiting skeletal muscle myopathy and cardiac in mice was shown to result in severe perimyocarditis hypertrophy has been reported. This model was created by resembling viral myocarditis or autoimmune diseases knockout of the heart / muscle isoform of the adenine [182, 183] . nucleotide translocator (Ant1) [169] .
12. Animal models of heart failure and hypertrophy 11. Recent animal models of myocarditis in the past, present and future Several animal models of myocarditis have been deBesides basic ethical and philosophical questions, the veloped and progression to dilated cardiomyopathy and use of animal models of heart failure and hypertrophy heart failure occurs in some of those [170] [171] [172] [173] [174] . Congesneeds careful consideration because of at least two reasons: tive heart failure develops after an acute phase of myocar-(1) the disease may be associated with discomfort and pain ditis induced by the M variant of the encephalomyocarditis to the animal, and (2) results from animal studies are not virus [175] . Myocyte necrosis and biventricular dilatation readily transferable to the situation in patients with heart occur during the phase of viremia, and signs of CHF were failure. observed at 7 to 14 days after inoculation. Altered myocarIn the past, a large number of studies have been dial function is associated with neurohumoral activation. performed in animals with overt clinical heart failure to Potential mechanisms contributing to the progression of evaluate pathophysiology from the level of the intact CHF include a persistence of the viral RNA within the instrumented animal to the tissue homogenate. These kind myocardium, viral-mediated cytokine production with conof studies brought a lot of information on hemodynamics, tinued myocytolysis, a prolonged immune response, and neurohumoral activation, myocardial function and subcelcontinued fibrosis and abnormalities in microcirculatory lular and molecular alterations in the failing heart. There function. Interestingly, tumor necrosis factor (TNF) was are great differences between species and models and only elevated in this model and an exogenously administered some models mimic human heart failure in some aspects. anti-TNF antibody improved survival and reduced the These kind of studies seem to be less important in the myocardial lesion, suggesting the importance of TNF in presence because with recent invasive and noninvasive the pathogenesis [176] .
technologies hemodynamics can be studied in patients. Another widely used model is based on experimental Furthermore, with cardiac transplantation surgery, endautoimmune myocarditis [177] . This model has been stage failing human myocardium became available for applied to different species. The model resembles human functional, biochemical and molecular biology studies giant cell myocarditis. It was shown that myocarditis and allowing the evaluation of alterations which are present in hemodynamic deterioration developed within 21 days after end-stage failure in the human heart itself. However, it is immunization of rats with cardiac myosin. This was rather difficult or impossible to study myocardial changes alpha and tumor necrosis factor receptors in the failing human heart. during compensated, less-severe stages of CHF, during the and heart failure models in mice will be used in the future 
